dr. chi on androgen deprivation therapy for high-risk metastatic hormone-naive prostate cancer
Published 7 years ago • 359 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
0:55
dr. chi on combinations with androgen deprivation therapy for prostate cancer
-
7:25
optimizing androgen deprivation therapy in high-risk prostate cancer
-
12:11
triggers to initiate androgen-deprivation therapy (adt) in prostate cancer
-
6:14
intermittent versus continuous androgen-deprivation therapy in prostate cancer
-
6:15
androgen deprivation therapy for prostate cancer: involving primary care
-
1:18
results of the latitude trial in high-risk metastatic hormone-naive prostate cancer
-
1:00
dr. aggarwal on androgen deprivation therapy for prostate cancer
-
1:37
dr. james mohler discusses androgen-deprivation therapy for prostate cancer
-
6:48
docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer
-
23:54
the abcs of androgen deprivation therapy
-
32:28
prostate cancer and androgen deprivation therapy
-
17:02
androgen deprivation therapy and prostate cancer
-
55:38
expert angle: androgen deprivation therapy and advanced prostate cancer
-
2:00
improving androgen-deprivation therapy for prostate cancer
-
6:40
considerations for initiating adt in prostate cancer
-
31:24
optimizing androgen deprivation therapy (adt) in advanced prostate cancer
-
51:42
2/2/18: androgen deprivation therapy in prostate cancer: adverse effects and strategies to mitigate
-
30:48
hormone therapy & advanced therapies for prostate cancer, celestia higano, md | 2021 mid-year update
-
11:48
localized prostate cancer: androgen deprivation therapy (adt) - 2021 prostate cancer conference